(19)
(11) EP 4 493 154 A1

(12)

(43) Date of publication:
22.01.2025 Bulletin 2025/04

(21) Application number: 24704018.1

(22) Date of filing: 09.02.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/14(2017.01)
 A61K 9/107(2006.01)
A61K 31/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/658; A61K 9/006; A61K 9/0056; A61K 47/14; A61K 9/1075
(86) International application number:
PCT/EP2024/053325
(87) International publication number:
WO 2024/165731 (15.08.2024 Gazette 2024/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 10.02.2023 WO PCT/EP2023/053308

(71) Applicant: TETRA PHARM TECHNOLOGIES
3400 Hillerød (DK)

(72) Inventors:
  • ROSE, Martin
    3400 Hillerød (DK)
  • BREUM, Jesper
    2000 Frederiksberg C (DK)
  • ALLESØ, Morten
    2650 Hvidovre (DK)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) A CANNABINOID-BASED OIL-IN-WATER EMULSION FOR SUBLINGUAL AND BUCCAL ADMINISTRATION